Stock PTPI PETROS PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Petros Pharmaceuticals

Equities

PTPI

US71678J2096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.6399 USD 0.00% Intraday chart for Petros Pharmaceuticals -4.51% -54.62%
Apr. 23 Petros, Lemonaid Health Collaborate to Expand Stendra Availability MT
Apr. 23 Petros Pharmaceuticals, Inc. Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Health CI

Evolution of the average Target Price on Petros Pharmaceuticals

Price target over the last 5 years

History of analyst recommendation changes

b43d396cd1faab40da.sUZ1eqPx_GBJM-plI1CGBi1polNM0Rk6u6Ega0bF5_Y.-39NTuiBulY8UZoqcD-yZE4v6RcnnVdiypMZERy_ga6FMAU3lpSaDy56nQ~28e58541198e99aafac75cbc4e64f54b

Analyst Recommendations on Petros Pharmaceuticals

Maxim Initiates Petros Pharma at Buy Rating With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.6399 USD
Average target price
4 USD
Spread / Average Target
+525.10%
High Price Target
4 USD
Spread / Highest target
+525.10%
Low Price Target
4 USD
Spread / Lowest Target
+525.10%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Petros Pharmaceuticals

Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PTPI Stock
  4. Consensus Petros Pharmaceuticals